As of 4:00pm ET
| +0.19 / +2.76%|
The 6 analysts offering 12-month price forecasts for Arrowhead Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 15.00 and a low estimate of 5.50. The median estimate represents a +27.12% increase from the last price of 7.08.
The current consensus among 6 polled investment analysts is to Buy stock in Arrowhead Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.